REGENXBIO Inc. Employee Count
The employee counts REGENXBIO Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 371; Filing 2026-03-05; Lease expense per employee $37,382.75.
- 2024-12-31: Employees (as filed) 353; Filing 2025-03-13; Lease expense per employee $38,453.26.
- 2023-12-31: Employees (as filed) 344; Filing 2024-02-27; Lease expense per employee $38,866.28.
- 2022-12-31: Employees (as filed) 401; Filing 2023-02-28; Lease expense per employee $28,172.07.
- Available history
- 2016-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 371 full-time | 2026-03-05 | $37,382.75 total lease cost |
| 2024-12-31 | 353 full-time | 2025-03-13 | $38,453.26 total lease cost |
| 2023-12-31 | 344 full-time | 2024-02-27 | $38,866.28 total lease cost |
| 2022-12-31 | 401 full-time | 2023-02-28 | $28,172.07 total lease cost |
| 2021-12-31 | 372 full-time | 2022-03-01 | $32,465.05 total lease cost |
| 2020-12-31 | 306 full-time | 2021-03-01 | $20,751.63 total lease cost |
| 2019-12-31 | 257 full-time | 2020-02-26 | $14,420.23 total lease cost |
| 2018-12-31 | 192 full-time | 2019-02-27 | $14,583.33 rent expense, net |
| 2017-12-31 | 139 full-time | 2018-03-06 | $12,949.64 rent expense, net |
| 2016-12-31 | 107 full-time | 2017-03-07 | $16,822.43 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |